SCHEMBL7184029

SCHEMBL7184029

Cc1ccccc1Cn1ccc(C(=O)CC(=O)C(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 7/20 0.49
FEN1 P39748 7/20 0.49
PTPN1 P18031 2/20 0.47
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
HAO1 Q9UJM8 1/20 0.43
HTT P42858 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
KDM4E B2RXH2 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 2/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KLKB1 P03952 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AKR1B1 P15121 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184197 0.82 FEN1 (0.54) ERCC5FEN1PTPN1HAO1KLKB1
SCHEMBL28008353 0.80 CYP11B1 (0.46) ALDH1A1HPGDHTTLMNASMN1; SMN2
SCHEMBL7191520 0.78 ERCC5 (0.43) ERCC5FEN1PTPN1ALDH1A1HAO1
SCHEMBL7190675 0.77 ALDH1A1 (0.43) ERCC5FEN1PTPN1ALDH1A1HTT
SCHEMBL7188720 0.75 ERCC5 (0.50) ERCC5FEN1PTPN1ALDH1A1HPGD
SCHEMBL7196180 0.74 FEN1 (0.59) ERCC5FEN1PTPN1ALDH1A1HAO1
SCHEMBL7188845 0.73 POLB (0.46) ERCC5FEN1PTPN1HAO1CYP11B1
SCHEMBL7183825 0.73 HAO1 (0.54) ERCC5FEN1PTPN1ALDH1A1HAO1
SCHEMBL7189635 0.73 ERCC5 (0.50) ERCC5FEN1KDM4EKMT2A
SCHEMBL7186586 0.72 KLKB1 (0.44) ERCC5FEN1PTPN1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP claimed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US claimed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP claimed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO claimed
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP disclosed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US disclosed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP disclosed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO disclosed